(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Pite ≥98.0% (HPLC) Rivaroxaban Entèmedyè Faktori
Manifakti Pwovizyon pou Rivaroxaban Entèmedyè ki gen rapò:
(S)-(+)-Glycidyl Phtalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0
Rivaroxaban Entèmedyè CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Asid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8
| Non Chimik | (S)-(+)-Glycidyl Phtalimide |
| Sinonim | (S)-Glycidyl Phtalimide;(S)-N-glisidilftalimid;Rivaroxaban Entèmedyè |
| Nimewo CAS | 161596-47-0 |
| Nimewo CAT | RF-PI128 |
| Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
| Fòmil molekilè | C11H9NO3 |
| Pwa molekilè | 203.19 |
| Pwen k ap fonn | 102℃ |
| Mak | Ruifu Chimik |
| Atik | Espesifikasyon |
| Aparans | Poud blan pou blan |
| Idantifikasyon | HPLC |
| Pèt sou siye | ≤0.50% |
| Silfat Ash | ≤0.50% |
| Pite / Metòd analiz | ≥98.0% (HPLC) |
| Ftalimid | ≤0.10% |
| Single Max enpurte | ≤0.50% |
| Enpurte total | ≤2.0% |
| Epichlorhydrin | ≤0.10% |
| Glicidol | ≤0.10% |
| Pite chiral | R-izomè ≤2.0% (HPLC) |
| Tès Creole | Enterprise Standard |
| Itilizasyon | Rivaroxaban (CAS: 366789-02-8) Entèmedyè |
(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Sentèz Route
Shanghai Ruifu Chemical co, Ltd se dirijan manifakti ak founisè nan (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) ak kalite siperyè.Li se yon entèmedyè tipikman nan sentèz la nan Rivaroxaban (CAS: 366789-02-8), nan tretman an nan venn Tromboembolism (VTE).
Rivaroxaban (Xarelto; CAS: 366789-02-8) se yon dwòg antitrombotik e li te devlope nan yon kolaborasyon ant Alman Bayer Pharmaceuticals ak konpayi Ameriken Johnson.Rivaroxaban endike pou tretman tronboz venn gwo twou san fon ak anbolis poumon, ak prevansyon tronboz venn fon frekan ak anbolis poumon nan granmoun.
